Abstract:Background Lung cancer is the leading cause of cancer death worldwide. However, the molecular mechanisms underlying lung cancer development have not been fully understood. The functions of histone deacetylases (HDACs), a class of total eighteen proteins (HDAC1–11 and SIRT1–7 in mammals) that deacetylate histones and non-histone proteins, in cancers are largely unknown. Methods Hdac7 +/− / K-Ras mice and HDAC7 -depleted human lung cancer cell lines were used as models for studying the function of Hdac7 gene in lung cancer. Kaplan-Meier survival analysis was performed to explore the relationship between HDAC7 expression and prognosis of human lung cancers. Recombinant lentivirus-mediated in vivo gene expression or knockdown, Western blotting, and pull-down assay were applied to investigate the underlying molecular mechanism by which Hdac7 promotes lung tumorigenesis. Results The number and burden of lung tumor were dramatically reduced in Hdac7 +/− / K-Ras mice compared to control K-Ras mice. Also, in Hdac7 +/− / K-Ras mice, cell proliferation was significantly inhibited and apoptosis in lung tumors was greatly enhanced. Similarly, cell proliferation and anchorage-independent growth of human lung cancer cell lines expressing shHDAC7 were also significantly suppressed and apoptosis was dramatically elevated respectively. Mechanistic study revealed that Hdac7 mutation in mouse lung tumors or HDAC7 depletion in human tumor cell lines resulted in significantly enhanced acetylation and tyrosine-phosphorylation of Stat3 and HDAC7 protein directly interacted with and deacetylateed STAT3. The Hdac7 mutant-mediated inhibitory effects on lung tumorigenesis in mice and cell proliferation/soft agar colony formation of human lung cancer cell lines were respectively reversed by expressing dnStat3 . Finally, the high HDAC7 mRNA level was found to be correlated with poor prognosis of human lung cancer patients. Conclusion Our study suggests that Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation via deacetylating Stat3 and may shed a light on the design of new therapeutic strategies for human lung cancer.

Stat3 Inhibits PTPN13 Expression in Squamous Cell Lung Carcinoma Through Recruitment of HDAC5

STAT1 Inhibits Human Hepatocellular Carcinoma Cell Growth Through Induction of P53 and Fbxw7

HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Data from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

PTPN3 Acts As a Tumor Suppressor and Boosts TGF-β Signaling Independent of Its Phosphatase Activity.

STAT5A Modulates CDYL2/SLC7A6 Pathway to Inhibit the Proliferation and Invasion of Hepatocellular Carcinoma by Targeting to Mtorc1

Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation

The Interaction of Interleukin-8 and PTEN Inactivation Promotes the Malignant Progression of Head and Neck Squamous Cell Carcinoma Via the STAT3 Pathway

Reciprocal Inhibition Between TP63 and STAT1 Regulates Anti-Tumor Immune Response Through Interferon-Γ Signaling in Squamous Cancer

STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC

Stat3 Downstream Genes Serve As Biomarkers in Human Lung Carcinomas and Chronic Obstructive Pulmonary Disease.

The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma.

TLX3 Repressed SNAI1-induced Epithelial-Mesenchymal Transition by Directly Constraining STAT3 Phosphorylation and Functionally Sensitized 5-FU Chemotherapy in Hepatocellular Carcinoma

Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression

STAT3 promotes RNA polymerase III-directed transcription by controlling the miR-106a-5p/TP73 axis

Histones Methyltransferase NSD3 Inhibits Lung Adenocarcinoma Glycolysis Through Interacting with PPP1CB to Decrease STAT3 Signaling Pathway

Tumour-suppressive Role of PTPN13 in Hepatocellular Carcinoma and Its Clinical Significance

Stat3 Activation Regulates the Expression of Vascular Endothelial Growth Factor and Human Pancreatic Cancer Angiogenesis and Metastasis

Targeted Inhibition of STAT3 Induces Immunogenic Cell Death of Hepatocellular Carcinoma Cells Via Glycolysis

IL-6 Induces Tumor Suppressor Protein Tyrosine Phosphatase Receptor Type D by Inhibiting Mir-34A to Prevent IL-6 Signaling Overactivation.

STAT3 Aggravates TGF-β1-induced Hepatic Epithelial-to-mesenchymal Transition and Migration.